Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Gustoeson Jun 27, 2019 10:30am
91 Views
Post# 29869495

RE:RE:How to get rich with no risk

RE:RE:How to get rich with no risk
CAinPlap wrote: The question I have is why the games with the cancelling the existing shelf prospectus? If that was still in place, would yesterdays announcement contain the terms rather than giving the market the heads up to sell or short in anticipation of the coming PP? As beenthere mentioned earlier, some of us have seen this movie play out before and its sucks! You can bet that we will get shorted and sold down into oblivion and then they will set a strike price based on the artificially created low shareprice with further "standard discount" to market. Then surprise surprise we are oversubscribed when the terms are announced and they will say with a straight face that that was the best effort. If oversubscribed, they obviously set the bar too low.  That is the part that leaves the worse taste in my mouth.




Possibly they were looking at  a bigger financing,,, someone wanted a big piece but either they didn't like something or wanted terms that TLT could not agree to. Based on science and expecations, I'm leaning towards TLT is going the short route here vs giving up bigger junk or poor terms when they know what is around the corner. If that's the case, this should be the last one. 35m shares, 15m in the bank. Fully diluted 200m shares. Not bad at all considering we're p2 human clinicals already with so many more possibilities. Short term blip for dilution adjustment.. which is silly but that's the way it works... then take off. Once the money is in the bank, any major catalyst will give us a summer to remember.

Bullboard Posts